FI842815A - Foerening och komposition foer terapeutisk eller diagnostisk anvaendning och terapeutisk behandlingsmetod. - Google Patents

Foerening och komposition foer terapeutisk eller diagnostisk anvaendning och terapeutisk behandlingsmetod. Download PDF

Info

Publication number
FI842815A
FI842815A FI842815A FI842815A FI842815A FI 842815 A FI842815 A FI 842815A FI 842815 A FI842815 A FI 842815A FI 842815 A FI842815 A FI 842815A FI 842815 A FI842815 A FI 842815A
Authority
FI
Finland
Prior art keywords
therapeutic
och
sub
diagnostic
behandlingsmetod
Prior art date
Application number
FI842815A
Other languages
English (en)
Other versions
FI842815A0 (fi
Inventor
Karl-Anders Karlsson
Alf Anton Lindberg
Original Assignee
Karlsson Karl Anders
Alf Anton Lindberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karlsson Karl Anders, Alf Anton Lindberg filed Critical Karlsson Karl Anders
Publication of FI842815A0 publication Critical patent/FI842815A0/fi
Publication of FI842815A publication Critical patent/FI842815A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/25—Shigella (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI842815A 1983-07-15 1984-07-12 Foerening och komposition foer terapeutisk eller diagnostisk anvaendning och terapeutisk behandlingsmetod. FI842815A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8304007A SE8304007D0 (sv) 1983-07-15 1983-07-15 Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling

Publications (2)

Publication Number Publication Date
FI842815A0 FI842815A0 (fi) 1984-07-12
FI842815A true FI842815A (fi) 1985-01-16

Family

ID=20351988

Family Applications (1)

Application Number Title Priority Date Filing Date
FI842815A FI842815A (fi) 1983-07-15 1984-07-12 Foerening och komposition foer terapeutisk eller diagnostisk anvaendning och terapeutisk behandlingsmetod.

Country Status (9)

Country Link
US (1) US4724205A (fi)
EP (1) EP0132242B1 (fi)
JP (1) JPS6064927A (fi)
AT (1) ATE96324T1 (fi)
AU (1) AU581851B2 (fi)
DE (1) DE3486236T2 (fi)
DK (1) DK168272B1 (fi)
FI (1) FI842815A (fi)
SE (1) SE8304007D0 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
DK455088D0 (da) * 1988-08-12 1988-08-12 Symbicom Ab Syntetiske receptoranaloger
SE9003222L (sv) * 1990-10-10 1992-04-11 Jens Sandros Preparat foer profylaktiskt,terapeutiskt och diagnostiskt bruk vid infektioner
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
US5310542A (en) * 1991-12-31 1994-05-10 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing antiplaque agents
US6727061B2 (en) * 1997-02-20 2004-04-27 Cabtec, Inc. Methods for identifying species or Shigella and E. coli using operon sequence analysis
US5888750A (en) * 1997-05-30 1999-03-30 Synsorb Biotech, Inc. Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
US7135173B2 (en) * 2000-07-13 2006-11-14 Idaho Research Foundation, Inc. Antiviral activity of Shiga toxin
US6541013B1 (en) 2000-07-13 2003-04-01 Idaho Research Foundation, Inc. Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US3891508A (en) * 1973-06-01 1975-06-24 Joseph M Merrick Method of rapid identification of gram-negative bacteria
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0058665B1 (en) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
EP0089940A1 (en) * 1982-03-23 1983-09-28 BioCarp AB Compositions for therapeutic or diagnostic use containing oligosaccharides
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling

Also Published As

Publication number Publication date
DK347784D0 (da) 1984-07-13
JPS6064927A (ja) 1985-04-13
DK347784A (da) 1985-01-16
EP0132242A2 (en) 1985-01-23
AU3052884A (en) 1985-01-17
EP0132242B1 (en) 1993-10-27
DE3486236T2 (de) 1994-02-24
SE8304007D0 (sv) 1983-07-15
DE3486236D1 (de) 1993-12-02
DK168272B1 (da) 1994-03-07
AU581851B2 (en) 1989-03-09
ATE96324T1 (de) 1993-11-15
EP0132242A3 (en) 1989-02-08
FI842815A0 (fi) 1984-07-12
US4724205A (en) 1988-02-09

Similar Documents

Publication Publication Date Title
FI842815A0 (fi) Foerening och komposition foer terapeutisk eller diagnostisk anvaendning och terapeutisk behandlingsmetod.
ES8306767A1 (es) "metodo de preparar compuestos esteroidicos antiinflamatorios".
FI864150A (fi) Kemiska foereningar.
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
EP0133170A3 (en) A compound and a composition for therapeutic or diagnostic use and a method for therapeutic treatment
DE3686197D1 (de) Pigmentzusammensetzung.
IT1264563B1 (it) Composti fotocromatici e metodo per la loro preparazione
PH16317A (en) Piperidylidene derivatives,pharmaceutical composition containing same and method of use thereof
SE8100134L (sv) Terpenoider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
SE7910072L (sv) Pyrrolo- eller pyrido(2,1-c)(1,4)tiaziner eller -tiazepiner
FI840660A (fi) (1,2-difenyl-etylenamin)-plati- na(ii)- komplexfoereningar.
AU6826887A (en) 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
ATE73136T1 (de) Verfahren zur herstellung von 6alpha, 9alphadifluor-11beta, 17alpha-dihydroxy-16alpha-methyl4-pregnen-3,20-dion und dessen derivate.
ES2051765T3 (es) 13 alfa-alquilgon-delta9(11)-en-5,10-epoxidos.
SE7704830L (sv) Indazolderivat
GR74870B (fi)
ATE77744T1 (de) Verwendung von pyrrothinderivaten.
SE8303569L (sv) Polyprenylforeningar
FI824155A0 (fi) Foerfarande foer framstaellning av 3,7a-diazacyklohepta/j,k/fluoren
KR840004431A (ko) 히단토인 치료제
SG36885G (en) Androstane carbothioates
ES478932A1 (es) Un procedimiento para la preparacion de analogos de cefalos -porina.
JPS5430108A (en) Diyne-type polyprenyl alcohol and hypotensive agent containing the same

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SYMBICOM AB